Suppr超能文献

病例报告:一个家族性血液学谱系显示,VHL种系突变是主要的易患因素,其他突变调节表型异质性。

Case Report: A familial hematological pedigree reveals VHL germline mutation as a principal predisposition factor with additional mutations modulating phenotypic heterogeneity.

作者信息

Chen HuiLing, Hu Wanli, Ma Chengcheng, Zhang Miaomiao, Yang Fuhua, Zeng Pengyun

机构信息

Department of Hematology, Lanzhou University Second Hospital, Lanzhou, Gansu, China.

The Second Clinical Medicine School, Lanzhou University, Lanzhou, Gansu, China.

出版信息

Front Oncol. 2025 Jul 29;15:1630715. doi: 10.3389/fonc.2025.1630715. eCollection 2025.

Abstract

BACKGROUND

VHL germline mutations are classically associated with von Hippel-Lindau syndrome, but their role in hematological malignancies remains underexplored.

METHODS

We analyzed a pedigree with acute myeloid leukemia (AML) proband and two offspring: primary immune thrombocytopenia (ITP) and acute T-cell lymphoblastic leukemia (T-ALL) via targeted sequencing and familial validation.

RESULTS

Genetic analysis revealed: (1) the proband carried concurrent VHL, ASXL3, and CCR7 germline mutations along with acquired BCOR/NF1 variants; (2) the ITP-affected offspring inherited ASXL3/CCR7 mutations only; and (3) the T-ALL case exhibited solely the VHL mutation. Acquired mutations (e.g., BCOR/NF1) in the proband suggest a 'two-hit' model for leukemogenesis.

CONCLUSION

This study identifies VHL as the principal predisposing mutation in a familial hematologic malignancy pedigree presenting with heterogeneous phenotypes, where ASXL3/CCR7 variants may serve as phenotypic modifiers. These findings advocate for genotype-driven surveillance strategies in familial hematological disorders.

摘要

背景

VHL基因种系突变通常与冯·希佩尔-林道综合征相关,但其在血液系统恶性肿瘤中的作用仍未得到充分研究。

方法

我们通过靶向测序和家族验证分析了一个家系,该家系的先证者患有急性髓系白血病(AML),两个后代分别患有原发性免疫性血小板减少症(ITP)和急性T淋巴细胞白血病(T-ALL)。

结果

基因分析显示:(1)先证者同时携带VHL、ASXL3和CCR7基因种系突变以及获得性BCOR/NF1变异;(2)受ITP影响的后代仅遗传了ASXL3/CCR7突变;(3)T-ALL病例仅表现出VHL突变。先证者中的获得性突变(如BCOR/NF1)提示白血病发生的“双打击”模型。

结论

本研究确定VHL是一个表现出异质性表型的家族性血液系统恶性肿瘤家系中的主要易感突变,其中ASXL3/CCR7变异可能作为表型修饰因子。这些发现支持在家族性血液系统疾病中采用基因型驱动的监测策略。

本文引用的文献

1
[Analysis of Frequencies and Subsets of Peripheral Helper T Cells in Patients with Immune Thrombocytopenia].
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2024 Oct;32(5):1518-1523. doi: 10.19746/j.cnki.issn.1009-2137.2024.05.033.
3
ZAP-70 augments tonic B-cell receptor and CCR7 signaling in IGHV-unmutated chronic lymphocytic leukemia.
Blood Adv. 2024 Mar 12;8(5):1167-1178. doi: 10.1182/bloodadvances.2022009557.
4
mutations are associated with a response to alvocidib and 5-azacytidine combination in myelodysplastic neoplasms.
Haematologica. 2024 May 1;109(5):1426-1438. doi: 10.3324/haematol.2023.282921.
5
JAK2 unmutated erythrocytosis: 2023 Update on diagnosis and management.
Am J Hematol. 2023 Jun;98(6):965-981. doi: 10.1002/ajh.26920. Epub 2023 Apr 3.
6
Regulation of Erythropoiesis by the Hypoxia-Inducible Factor Pathway: Effects of Genetic and Pharmacological Perturbations.
Annu Rev Med. 2023 Jan 27;74:307-319. doi: 10.1146/annurev-med-042921-102602. Epub 2022 Jun 30.
7
The Role of VHL in the Development of von Hippel-Lindau Disease and Erythrocytosis.
Genes (Basel). 2022 Feb 17;13(2):362. doi: 10.3390/genes13020362.
8
Therapeutic targeting of BAP1/ASXL3 sub-complex in ASCL1-dependent small cell lung cancer.
Oncogene. 2022 Apr;41(15):2152-2162. doi: 10.1038/s41388-022-02240-x. Epub 2022 Feb 22.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验